Inhibition of human immunodeficiency virus (HIV) replication by HIV-trans-activated alpha 2-interferon
about
Mechanism of inhibition of retrovirus release from cells by interferon-induced gene ISG15The IFITM proteins inhibit HIV-1 infectionMajor depletion of plasmacytoid dendritic cells in HIV-2 infection, an attenuated form of HIV diseaseA suicide gene approach using the human pro-apoptotic protein tBid inhibits HIV-1 replicationInhibition of replication of reactivated human immunodeficiency virus type 1 (HIV-1) in latently infected U1 cells transduced with an HIV-1 long terminal repeat-driven PKR cDNA constructGene therapy for infectious diseasesCharacterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells.Gene therapy for HIV.Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15.Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cellsInhibition of HIV type 1 replication in CD4+ and CD14+ cells purified from HIV type 1-infected individuals by the 2-5A agonist immunomodulator, 2-5A(N6B).Blockade of human immunodeficiency virus type 1 production in CD4+ T cells by an intracellular CD4 expressed under control of the viral long terminal repeat.Gö 6976, a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent/low-level-producing reservoir cells in vitro.Breaking Barriers to an AIDS Model with Macaque-Tropic HIV-1 Derivatives.Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro.A reasonable Approach for the Treatment of HIV Infection in the Early Phase with Ozonetherapy (Autohaemotherapy). How 'Inflammatory' Cytokines may have A therapeutic Role.The presence of tat protein or tumor necrosis factor alpha is critical for herpes simplex virus type 1-induced expression of human immunodeficiency virus type 1.Differential replication of human immunodeficiency virus type 1 in CD8- and CD8+ subsets of natural killer cells: relationship to cytokine production pattern.Stable antiviral expression in BALB/c 3T3 cells carrying a beta interferon sequence behind a major histocompatibility complex promoter fragment.Differential susceptibilities of U-937 cell clones to infection by human immunodeficiency virus type 1.Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle.Selective killing of CD4+ cells harboring a human immunodeficiency virus-inducible suicide gene prevents viral spread in an infected cell population.A variant macaque-tropic human immunodeficiency virus type 1 is resistant to alpha interferon-induced restriction in pig-tailed macaque CD4+ T cellsSIV infection of rhesus macaques differentially impacts mononuclear phagocyte responses to virus-derived TLR agonists.Partial inhibition of human immunodeficiency virus replication by type I interferons: impact of cell-to-cell viral transferInhibition by interferon of herpes simplex virus type 1-activated transcription of tat-defective provirusInnate antiviral response: role in HIV-1 infection.The tug-of-war between dendritic cells and human chronic viruses.Complex Interplay between HIV-1 Capsid and MX2-Independent Alpha Interferon-Induced Antiviral Factors.Evidence for a different susceptibility of primate lentiviruses to type I interferons.Coordinate enhancement of cytokine gene expression in human immunodeficiency virus type 1-infected promonocytic cells.Interference with human immunodeficiency virus (HIV) replication by CD8+ T cells in peripheral blood leukocytes of asymptomatic HIV carriers in vitro.Chromosome 9 short arm deletions in malignant diseases.Identification and analysis of antisense RNA target regions of the human immunodeficiency virus type 1.Inhibition of human immunodeficiency virus (HIV-1) replication in SupT1 cells transduced with an HIV-1 LTR-driven PKR cDNA construct.A human T lymphotropic virus type I (HTLV-I) long terminal repeat-directed antisense c-myc construct with an Epstein-Barr virus replicon vector inhibits cell growth in a HTLV-I-transformed human T cell line.Budding of Enveloped Viruses: Interferon-Induced ISG15-Antivirus Mechanisms Targeting the Release ProcessCell and Gene Therapy for HIV Cure.Interferon-α Subtypes As an Adjunct Therapeutic Approach for Human Immunodeficiency Virus Functional Cure.
P2860
Q24301430-6C3C36D5-7A61-4BFF-80BB-402BDD868727Q24629626-F11D6B18-CB3A-4C47-827D-37D18B3D2FFDQ30912292-C71B86AF-B5ED-4C40-AF16-4FF2BAFA9CD8Q33790492-55F02DCE-2C1A-4E92-B0C9-DB20B19D8229Q33822538-7B33048C-3B82-4EC6-A530-FE53E6F21696Q33992464-10D42487-19E1-477C-8B83-E0D5E62A8693Q34120302-6DD8C5B5-4694-4ECF-B684-2D96832E7B31Q34208320-FE465602-A63C-409D-8386-BA6D48CBD254Q34335062-D4D059A8-CA8B-417B-AB43-8A65FC018E4EQ35828854-75EF6639-B7FE-400A-B5A5-E1399016A51DQ35928364-7AAC7C58-0D26-42FC-BE89-E885BDC05BEAQ36193108-897D8F35-EF2F-423B-944C-A575C4AB3A01Q36311350-68F24B35-1320-4B03-8268-916067E6AB40Q36537806-D55A449E-0750-47C2-B721-1E4B0BC84FCEQ36540073-5F913162-D0AF-4E26-BB10-6E635FD97B79Q36627620-2D5F71E3-7F44-415C-94CC-5166A631F68DQ36628240-63E291B7-564A-4B00-AEDC-A9097A08A7FAQ36653202-6D63F31B-25DF-4AA9-B9E2-6671A5A81D9BQ36679871-E7AE265E-DDDA-48C3-8ACB-D28FCDC41144Q36690766-9A0328A6-F724-42FB-A4AC-CF01B17024FEQ36691272-160D4C73-7376-429B-BAC1-86B39D6A41EBQ36763035-3D37A415-13DD-4BF7-82D6-D664E3FC17C6Q36911742-50968EF9-B842-47B8-A8B8-BC950A373C52Q37184456-3A3DBB97-7D65-4A07-843C-33D6ABB1C3F5Q37365399-0CF3B12F-91CB-474E-8BD4-87AB35A67088Q37611462-4D7AD1BA-E053-4BE2-88F9-54DA062E26C2Q37945237-023532C6-A97D-45CF-9A3C-F11779BF1388Q37952807-1E897AFA-9F6E-4E1D-9729-CED0F88145B1Q38765585-5B6AD816-4CCD-4F4B-A0CF-64EE47FDE06CQ39223017-72BEF422-1E38-4B49-869B-4AF33CAD8E7BQ40105845-831C6CD0-FEB8-43C4-9144-5621136DD04CQ40109856-95F8CEC1-A3C0-41BD-8447-24A9AAA38C5AQ40384749-806D0A63-7496-4F52-ACEF-9C165E3F1D28Q40532462-7A2DC20C-23AE-4870-94DF-665A1F1669C4Q40928197-FBF90AE0-5029-4E43-8745-187EE2322513Q41554392-24F373DC-E348-4AFC-BD74-BF7C807929ABQ42180882-4EA0A634-5670-4F17-9832-67B217B55C9BQ47236016-A4AC80A5-062D-4998-A36F-36777D8EB78EQ55153874-73A06D57-5C10-4515-8AE0-C7524A1F5816
P2860
Inhibition of human immunodeficiency virus (HIV) replication by HIV-trans-activated alpha 2-interferon
description
1989 nî lūn-bûn
@nan
1989 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Inhibition of human immunodefi ...... s-activated alpha 2-interferon
@ast
Inhibition of human immunodefi ...... s-activated alpha 2-interferon
@en
type
label
Inhibition of human immunodefi ...... s-activated alpha 2-interferon
@ast
Inhibition of human immunodefi ...... s-activated alpha 2-interferon
@en
prefLabel
Inhibition of human immunodefi ...... s-activated alpha 2-interferon
@ast
Inhibition of human immunodefi ...... s-activated alpha 2-interferon
@en
P2093
P2860
P356
P1476
Inhibition of human immunodefi ...... s-activated alpha 2-interferon
@en
P2093
P2860
P304
P356
10.1073/PNAS.86.13.4958
P407
P577
1989-07-01T00:00:00Z